Drug Database
Back to search

Japan· JP-1319761Q1082

ブリモニジン酒石酸塩

A brimonidine product containing ブリモニジン酒石酸塩, registered in Japan by テイカ製薬, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

On Japan’s NHI price listATC D11AX21

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedブリモニジン酒石酸塩ATCD11AX21REGISTER NO.JP-1319761Q1082PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ブリモニジン酒石酸塩Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Brimonidine is registered in 13 of 19 countries.

Countries holding a registration under ATC D11AX21 (brimonidine), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 8 of them publish a price we can compare per daily dose
Search brimonidine products by name

Brimonidine · ATC D11AX21

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ブリモニジン酒石酸塩
Manufacturer
テイカ製薬
Country
Japan (JP)
ATC code
D11AX21
ATC class
Brimonidine
Defined daily dose
1.65 mg, T
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

567 interactions on record for brimonidine.

Graded by severity as the source publishes them — 387 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check brimonidine against other medicinesHow interaction checks work

Brimonidine · interactions on record

567 records

  • 387 moderate
  • 180 info

Most severe, free to view

  • PapaverineA03AD01moderate
  • MetoclopramideA03FA01moderate
  • DimenhydrinatA04AB02moderate
  • ThiethylperazinA04AB03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Brimonidine in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All brimonidine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Alpha-Vision Sine, Alphagan
  • Belgium · Alphagan, Lumobry
  • Bulgaria · Brimogen, Бримонидин Абр
  • Cyprus · Brimontal, Corneax
  • Czechia · Alphagan, Brimonidin Olikla
  • Germany · Alphagan, Brimo-Vision
  • Denmark · Alphagan, Brimonidintartrat 1a Farma
  • Spain · Abradel, Alphagan
  • Finland · Alphagan, Lumobry
  • France · Alphagan, Brimazed
  • United Kingdom (Northern Ireland) · Alphagan, Brimonidine Omnivision
  • Greece · Alphagan, Brimofree
  • Croatia · Alphagan, Bimanox
  • Hungary · Brimogen, Lumobry
  • Ireland · Alphagan, Lumobry
  • Iceland · Alphagan, Brimonidin Bluefish
  • Italy · Alphagan, Brimofree
  • Liechtenstein · Mirvaso
  • Lithuania · Brimonal, Brimonidine Tartrate Elvim
  • Luxembourg · Alphagan, Brimonidin Micro Labs
  • Latvia · Briglafre, Brimonal
  • Malta · Alphagan, Brimogan
  • Netherlands · Alphagan, Brimonidine Stulln
  • Norway · Alphagan, Brymont
  • Poland · Alphagan, Biprolast
  • Portugal · Alphagan, Bglau
  • Romania · Brimonal 2 Mg/Ml, Brimonidină Rompharm
  • Sweden · Alphagan, Brimonidin Bluefish
  • Slovenia · Bimanox, Luvify
  • Slovakia · Brimonal, Brimonidin Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a9334232-b3ad-4aab-a80c-1b9348527ce6
GET /v1/drugs/a9334232-b3ad-4aab-a80c-1b9348527ce6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "０．１％１ｍＬ",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "1319761Q1082",
  "category": "外用薬",
  "price_yen": 74.2,
  "generic_name": "ブリモニジン酒石酸塩",
  "product_name_jp": null,
  "therapeutic_class": "1319",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about brimonidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console